WORCESTER, Mass.--(BUSINESS WIRE)--RXi Pharmaceuticals Corporation (Nasdaq: RXII), a recognized leader in RNAi-based therapeutic discovery and development, today announced that the Company’s President and Chief Executive Officer, Noah D. Beerman, will present a corporate overview at the 9th Annual BIO Investor Forum on Wednesday, October 6, 2010 at 2:30 p.m. PT in San Francisco.
